Finance

Lists
Why is PMVP up ३.७२%?
Dive Deeper
PMVP:NASDAQ
PMV Pharmaceuticals Inc
US$ १.२६
+३.७२%
(+०.०४५) 1D
US$ १.२६
+०.४०% (+०.००५०)
After hours
Closed: अक्टोबर १९, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMVP...
Open
US$ १.२१
High
US$ १.२९
Low
US$ १.२१
Mkt. cap
९.४८ करोड
Avg. vol.
८.३७ लाख
Volume
०.००
52-wk high
US$ १.९१
52-wk low
US$ १.०२
EPS
-US$ १.४१
Beta
१.३६
Shares outstanding
७.५५ करोड
No. of employees
५४
Open
US$ १.२१
High
US$ १.२९
Low
US$ १.२१
Mkt. cap
९.४८ करोड
Avg. vol.
८.३७ लाख
Volume
०.००
52-wk high
US$ १.९१
52-wk low
US$ १.०२
EPS
-US$ १.४१
Beta
१.३६
Shares outstanding
७.५५ करोड
No. of employees
५४
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
२४ मिनेट पहिले
Should You Wait Until After the Midterm Elections to Buy the S&P 500?
The Arkansas Democrat-Gazette
The Arkansas Democrat-Gazette
·
२९ मिनेट पहिले
AI stocks recover some losses; rest of market shaky
FXStreet
FXStreet
·
२९ मिनेट पहिले
S&P 500: Tech rebound offsets broader weakness – Deutsche Bank
About PMV Pharmaceuticals Inc
CEO-
Employees५४
Founded२०१३
Headquarters-
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to PMVP in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PMVP in the last 3 months.
Highest
Current US$ १.२६
US$ ५.०० (+२९८.४१%)
Average
US$ ४.२० (+२३४.६६%)
Lowest
US$ ३.०० (+१३९.०४%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$ ५.००
+२९८.४%
09/08/2026
Unknown Analyst
Craig-Hallum
Buy
Reiterated
US$ ४.००
+२१८.७%
09/01/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
US$ ४.००
+२१८.७%
09/01/2026
Jay Olson
Oppenheimer
Buy
Reiterated
US$ ५.००
+२९८.४%
09/01/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
US$ ५.००
+२९८.४%
09/01/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
US$ ३.००
+१३९%
08/17/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Reiterated
US$ ३.००
+१३९%
08/17/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
05/12/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
US$ ४.००
+२१८.७%
11/13/2025
Last report
२०२६ अगस्ट १४
Fiscal period
Q2 2026
-US$ ०.३४ / -US$ ०.४०
+१५.००%beat
Revenue / Est. (USD)
- / ०.००
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१.८२ करोड
१.५८ करोड
१.५३ करोड
१.४७ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४३.१२ लाख
३४.१५ लाख
३६.८९ लाख
४२.०५ लाख
Operating expense
२.२५ करोड
१.९२ करोड
१.९० करोड
१.८९ करोड
Total operating expenses
२.२५ करोड
१.९२ करोड
१.९० करोड
१.८९ करोड
Operating income
-२.२५ करोड
-१.९२ करोड
-१.९० करोड
-१.८९ करोड
Other non operating income
-२३.०० हजार
-१.०० हजार
१.०० हजार
१०.०० हजार
EBT including unusual items
-२.११ करोड
-१.८० करोड
-१.८० करोड
-१.८१ करोड
EBT excluding unusual items
-२.११ करोड
-१.८० करोड
-१.८० करोड
-१.८१ करोड
Income tax expense
-६.०० हजार
२६.०० हजार
-
३.०० हजार
Effective tax rate
०.०३%
-०.१४%
-
-०.०२%
Other operating expenses
-
-
-
-
Net income
-२.११ करोड
-१.८० करोड
-१.८० करोड
-१.८१ करोड
Net profit margin
-
-
-
-
Earnings per share
-०.४०
-०.३४
-०.३४
-०.३४
Interest and investment income
१४.८० लाख
१२.३२ लाख
९.८० लाख
७.८८ लाख
Interest expense
-
-
-
-
Net interest expenses
१४.८० लाख
१२.३२ लाख
९.८० लाख
७.८८ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.२५ करोड
-१.९२ करोड
-१.९० करोड
-१.८९ करोड
Gain or loss from assets sale
-१.०० हजार
-
-
२५.०० हजार
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू